Literature DB >> 9191880

The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization.

K L Peterson1, W Zhang, P D Lu, S A Keilbaugh, E I Peerschke, B Ghebrehiwet.   

Abstract

Two types of widely coexpressed cell surface C1q-binding proteins (C1q-R): a 60-kDa calreticulin-homolog which binds to the collagen-like "stalk" of C1q and a 33-kDa protein with affinity for the globular "heads" of the molecule, have been described. In this report, we show that the two molecules are also secreted by Raji cells and peripheral blood lymphocytes and can be isolated in soluble form from serum-free culture supernatant by HPLC purification using a Mono-Q column. The two purified soluble proteins had immunochemical and physical characteristics similar to their membrane counterparts in that both bound to intact C1q and to their respective C1q ligands, cC1q and gC1q. In addition, N-terminal amino acid sequence analyses of the soluble cC1q-R and gC1q-R were found to be identical to the reported sequences of the respective membrane-isolated proteins. Ligand blot analyses using biotinylated membrane or soluble cC1q-R and gC1q-R showed that both bind to the denatured and nondenatured A-chain and moderately to the C-chain of C1q. Moreover, like their membrane counterparts, the soluble proteins were found to inhibit serum C1q hemolytic activity. Although cC1q-R was released when both peripheral blood lymphocytes and Raji cells were incubated in phosphate-buffered saline for 1 hr under tissue culture conditions, gC1q-R was releasable only from Raji cells, suggesting that perhaps activation or transformation leading to immortalization is required for gC1q-R release. Subcellular fractionation of Raji cells and analyses by enzyme-linked immunosorbent assay and Western blotting showed that the two molecules are present in the cytosolic fractions as well as on the membrane. The data suggest that soluble forms of both C1q-binding molecules are released from cells and that these molecules may play important roles in vivo as regulators of complement activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191880     DOI: 10.1006/clin.1997.4374

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  21 in total

Review 1.  C1q receptors.

Authors:  P Eggleton; A J Tenner; K B Reid
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

2.  Genetic variants associated with severe pneumonia in A/H1N1 influenza infection.

Authors:  J Zúñiga; I Buendía-Roldán; Y Zhao; L Jiménez; D Torres; J Romo; G Ramírez; A Cruz; G Vargas-Alarcon; C-C Sheu; F Chen; L Su; A M Tager; A Pardo; M Selman; D C Christiani
Journal:  Eur Respir J       Date:  2011-07-07       Impact factor: 16.671

3.  Soluble gC1qR is an autocrine signal that induces B1R expression on endothelial cells.

Authors:  Berhane Ghebrehiwet; Yan Ji; Alisa Valentino; Lina Pednekar; Mahalakshmi Ramadass; David Habiel; Richard R Kew; Kinga H Hosszu; Dennis K Galanakis; Uday Kishore; Ellinor I B Peerschke
Journal:  J Immunol       Date:  2013-12-06       Impact factor: 5.422

4.  Blockade of gC1qR/p33, a receptor for C1q, inhibits adherence of Staphylococcus aureus to the microvascular endothelium.

Authors:  Shneh Sethi; Mathias Herrmann; Jonas Roller; Lutz von Müller; Ellinor I Peerschke; Berhane Ghebrehiwet; Irma Bajric; Michael D Menger; Matthias W Laschke
Journal:  Microvasc Res       Date:  2011-04-22       Impact factor: 3.514

5.  gC1qR expression in normal and pathologic human tissues: differential expression in tissues of epithelial and mesenchymal origin.

Authors:  Francine R Dembitzer; Yayoi Kinoshita; David Burstein; Robert G Phelps; Mary Beth Beasley; Roberto Garcia; Noam Harpaz; Shabnam Jaffer; Swan N Thung; Pamela D Unger; Berhane Ghebrehiwet; Ellinor I Peerschke
Journal:  J Histochem Cytochem       Date:  2012-06       Impact factor: 2.479

6.  Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets.

Authors:  T Nguyen; B Ghebrehiwet; E I Peerschke
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Interaction between herpes simplex virus type 1 IE63 protein and cellular protein p32.

Authors:  H E Bryant; D A Matthews; S Wadd; J E Scott; J Kean; S Graham; W C Russell; J B Clements
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  gC1qR/p33 blockade reduces Staphylococcus aureus colonization of target tissues in an animal model of infective endocarditis.

Authors:  Ellinor I B Peerschke; Arnold S Bayer; Berhane Ghebrehiwet; Yan Q Xiong
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

9.  The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.

Authors:  S K Petersen-Mahrt; C Estmer; C Ohrmalm; D A Matthews; W C Russell; G Akusjärvi
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

10.  Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage.

Authors:  Domenico Sansonno; Felicia Anna Tucci; Berhane Ghebrehiwet; Gianfranco Lauletta; Ellinor I B Peerschke; Vincenza Conteduca; Sabino Russi; Pietro Gatti; Loredana Sansonno; Franco Dammacco
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.